Morgan Stanley’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-68,557
| Closed | -$20.4K | – | 7828 |
|
|
2023
Q2 | $20.4K | Sell |
68,557
-9,738
| -12% | -$2.9K | ﹤0.01% | 6562 |
|
|
2023
Q1 | $33.9K | Buy |
78,295
+16,228
| +26% | +$7.02K | ﹤0.01% | 6424 |
|
|
2022
Q4 | $73.2K | Buy |
62,067
+13,027
| +27% | +$15.4K | ﹤0.01% | 6118 |
|
|
2022
Q3 | $113K | Buy |
49,040
+32,118
| +190% | +$74K | ﹤0.01% | 6016 |
|
|
2022
Q2 | $38K | Buy |
16,922
+11,222
| +197% | +$25.2K | ﹤0.01% | 6738 |
|
|
2022
Q1 | $55K | Buy |
5,700
+5,200
| +1,040% | +$50.2K | ﹤0.01% | 6665 |
|
|
2021
Q4 | $5K | Sell |
500
-153
| -23% | -$1.53K | ﹤0.01% | 7664 |
|
|
2021
Q3 | $7K | Buy |
+653
| New | +$7K | ﹤0.01% | 7432 |
|